The launch and operational start of the Eagle Line has enabled QuantumScape (NYSE:QS) to initiate commercial sampling and ...

In just a few moments, we will provide an overview of our 2026 first quarter financial results. During today's presentation, we may make projections or other forward-looking statements regarding ...

Fountain: Thanks, Brantley, and thank you to everyone for joining our third quarter earnings call today. We are pleased to ...

Decreased by $100.8 million, attributed primarily to a seasonal decline in public funds deposits. Nonperforming assets ratio ...

Increased 10% quarter over quarter and 20% year over year, led by net interest income growth and higher loan sale activity.

Rezetapopt demonstrated a 44.4% overall response rate and durable responses lasting over eight months in patients with ...